Efficacy and safety study with alectinib in advanced ALK-positive non-small-cell lung cancer

被引：0
|
作者：
Fernandez Madrigal, Laura
Garcia Samblas, Victoria
Amor Urbano, Maria
Inoriza, Angel
机构：
[1] Hosp Juan Ramon Jimenez, Huelva, Spain
[2] Hosp Juan Ramon Jimenez, Oncol Med, Huelva, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21153
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Alectinib for advanced ALK-positive non-small-cell lung cancer
    Ly, Ashley C.
    Olin, Jacqueline L.
    Smith, Morgan B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (08) : 515 - 522
  • [2] Alectinib for ALK-positive non-small-cell lung cancer
    Rossi, Antonio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (08) : 1005 - 1013
  • [3] Alectinib for treatment of ALK-positive non-small-cell lung cancer
    Avrillon, Virginie
    Perol, Maurice
    FUTURE ONCOLOGY, 2017, 13 (04) : 321 - 335
  • [4] Alectinib in resected ALK-positive non-small-cell lung cancer
    Gourmet, Anais
    Ferrari, Victoria
    BULLETIN DU CANCER, 2024, 111 (10) : 905 - 906
  • [5] Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
    Wu, Yi-Long
    Dziadziuszko, Rafal
    Ahn, Jin Seok
    Barlesi, Fabrice
    Nishio, Makoto
    Lee, Dae Ho
    Lee, Jong-Seok
    Zhong, Wenzhao
    Horinouchi, Hidehito
    Mao, Weimin
    Hochmair, Maximilian
    de Marinis, Filippo
    Migliorino, M. Rita
    Bondarenko, Igor
    Lu, Shun
    Wang, Qun
    Ochi Lohmann, Tania
    Xu, Tingting
    Cardona, Andres
    Ruf, Thorsten
    Noe, Johannes
    Solomon, Benjamin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (14): : 1265 - 1276
  • [6] Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer
    Peters, Solange
    Camidge, D. Ross
    Shaw, Alice T.
    Gadgeel, Shirish
    Ahn, Jin S.
    Kim, Dong-Wan
    Ou, Sai-Hong I.
    Perol, Maurice
    Dziadziuszko, Rafal
    Rosell, Rafael
    Zeaiter, Ali
    Mitry, Emmanuel
    Golding, Sophie
    Balas, Bogdana
    Noe, Johannes
    Morcos, Peter N.
    Mok, Tony
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 829 - 838
  • [7] Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer
    Yu, Hui
    Sun, Si
    Hu, Xingjiang
    Xia, Jinjing
    Wang, Jialei
    Chen, Haiquan
    ONCOTARGETS AND THERAPY, 2019, 12 : 6481 - 6495
  • [8] A comparative evaluation of alectinib for ALK-positive non-small-cell lung cancer: A systematic review
    Kharat, Monica
    Nookala, Harshitha
    John, Jabez David
    Patel, Tirath
    Kalyandrug, Pragnesh
    Emmanuel, Sonya
    Noor, Anaya
    Halani, Dhruv Jignesh Kumar
    Goyal, Abhishek
    Anand, Nikhilesh
    Gadad, Bharathi
    Millis, Richard M.
    MEDICINE, 2025, 104 (07)
  • [9] Efficacy of Ceritinib After Alectinib for ALK-positive Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Tsuji, Takahiro
    Nomizo, Takashi
    Yasuda, Yuto
    Yamamoto, Tomoko
    Ajimizu, Hitomi
    Hirai, Toyohiro
    IN VIVO, 2018, 32 (06): : 1587 - 1590
  • [10] Updated Efficacy and Safety Data from the Phase 2 NP28761 Study of Alectinib in ALK-Positive Non-Small-Cell Lung Cancer
    Camidge, D. Ross
    Gadgeel, Shirish
    Ou, Sai-Hong
    Gandhi, Leena
    Riely, Gregory
    Cetnar, Jeremy
    West, Howard
    Socinski, Mark
    Chiappori, Alberto
    Mekhail, Tarek
    Chao, Bo
    Borghaei, Hossein
    Gold, Kathryn
    Bordogna, Walter
    Balas, Bogdana
    Noe, Johannes
    Golding, Sophie
    Zeaiter, Ali
    Shaw, Alice
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S378 - S378
12345